SYSTOLIC CARDIAC FUNCTION IN OBESITY AND EXERCISE

肥胖和运动中的心脏收缩功能

基本信息

  • 批准号:
    6783323
  • 负责人:
  • 金额:
    $ 8.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-01 至 2006-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from applicant's abstract) The candidate's immediate career goals are to study the role of the beta-receptor signaling pathway in mediating systolic dysfunction in obesity, and the role of exercise training in attenuating obesity-related cardiovascular defects. The Department of Integrative Physiology at the University of North Texas Health Science Center is uniquely suited to help the candidate achieve these goals. Within the department, there is a wide variety of expertise in human, animal, in vivo, and in vitro studies in cardiovascular physiology and endocrinology. This will aid in developing expertise with a variety of surgical, laboratory, and assay techniques to study cardiac function. Further, the Cardiovascular Research Institute at the University of North Texas Health Science Center provides access to research efforts of molecular biologists, pharmacologists, physiologists and physicians from within the institution and from nearby institutions. This will benefit career development by providing opportunities to integrate knowledge from many fields which impact cardiovascular research. The current proposal has three major goals: 1) to determine mechanisms associated with reduced cardiac contractile responsiveness to beta-adrenergic stimulation in obesity, 2) to determine the role of exercise training in attenuation of obesity-induced abnormalities in cardiac function, and 3) to determine the role of obesity, separate from hypertension, in contributing to systolic dysfunction in sedentary and trained animals. The investigators hypothesize that there are multiples sites of decreased activity in the beta- signaling pathway in obesity. Thus, they will use the rabbit method of dietary-induced obesity to compare function of lean animals with that of obese animals after 12 weeks of a high fat diet. They will use the Langendorff isolated heart preparation and appropriate assay and western blotting techniques to analyze the role of the beta-receptor and four sites of post- receptor activity in contributing to cardiac abnormalities in obesity. The investigators also hypothesize that exercise training during the development of obesity will attenuate or prevent obesity-related cardiovascular abnormalities. They will determine whether exercise training will 1) reduce obesity-related hypertension, resting tachycardia, and neurohumoral activation, and 2)attenuate obesity-related decreases in responsiveness to beta-adrenergic stimulation. They will examine hemodynamics and neurohumoral activation in vivo and use the isolated heart preparation to determine the role of exercise training in increasing responsiveness to beta-adrenergic stimulation. Finally, they hypothesize that obesity has an independent effect on cardiac hypertrophy and systolic dysfunction. They will test this hypothesis by maintaining blood pressure at control levels as obesity develops before testing for responsiveness to beta-adrenergic stimulation. Insight into mechanisms whereby obesity increases risk for congestive heart failure may lead to advances in therapeutic modalities for prevention and treatment of heart failure in obese patients. Information on mechanisms whereby exercise training may improve cardiovascular risk profile and cardiac performance in obesity may help reduce risk for development of cardiovascular diseases in obesity. Because such a large segment of the American population is overweight or obese, the knowledge and insight gained from these studies can have far-reaching effects.
描述 (改编自申请人的摘要)候选人的近期职业目标是 研究β受体信号通路在介导收缩期中的作用 肥胖症的功能障碍以及运动训练在减轻肥胖症中的作用 肥胖相关的心血管缺陷。 综合系 北德克萨斯大学健康科学中心的生理学是独一无二的 适合帮助候选人实现这些目标。 在部门内部, 在人类、动物、体内和体外方面有各种各样的专业知识 心血管生理学和内分泌学研究。 这将有助于 发展各种手术、实验室和化验方面的专业知识 研究心脏功能的技术。 此外,心血管研究 北德克萨斯大学健康科学中心研究所提供 获得分子生物学家、药理学家的研究成果, 来自机构内部和附近的生理学家和医生 机构。 这将通过提供机会有利于职业发展 整合影响心血管研究的多个领域的知识。 目前的提案有三个主要目标:1)确定机制 与β-肾上腺素能心脏收缩反应性降低有关 肥胖刺激,2) 确定运动训练在肥胖中的作用 减轻肥胖引起的心功能异常,3) 确定肥胖(与高血压分开)在促进 久坐和训练有素的动物的收缩功能障碍。 调查人员 假设β-中存在多个活性降低的位点 肥胖中的信号通路。 因此,他们将使用兔子方法 饮食引起的肥胖,比较瘦动物和肥胖动物的功能 高脂肪饮食 12 周后的动物。 他们将使用 Langendorff 离体心脏制备和适当的测定和蛋白质印迹 技术分析 β 受体和四个后位点的作用 受体活性导致肥胖症的心脏异常。 这 研究人员还假设,在发育过程中进行运动训练 肥胖会减轻或预防肥胖相关的心血管疾病 异常。 他们将确定运动训练是否会 1) 减少 肥胖相关高血压、静息心动过速和神经体液 激活,以及2)减轻肥胖相关的反应性下降 β-肾上腺素能刺激。他们将检查血流动力学和神经体液 体内激活并使用离体心脏制剂来确定 运动训练在提高β-肾上腺素能反应性中的作用 刺激。 最后,他们假设肥胖具有独立的影响 心脏肥大和收缩功能障碍。 他们将测试这个 随着肥胖的发展,将血压维持在控制水平的假设 在测试对β-肾上腺素能刺激的反应之前。 洞察力 肥胖增加充血性心力衰竭风险的机制 可能会导致预防和治疗疾病的治疗方式取得进展 肥胖患者的心力衰竭。 有关锻炼机制的信息 训练可以改善心血管风险状况和心脏功能 肥胖可能有助于降低患心血管疾病的风险 肥胖。 因为美国人口中有很大一部分是 超重或肥胖,从这些研究中获得的知识和见解可以 具有深远的影响。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hydralazine treatment alters body composition in the rabbit model of obesity.
肼屈嗪治疗改变了肥胖兔模型的身体成分。
  • DOI:
    10.1111/j.1365-201x.2004.01283.x
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Carroll,JoanF;King,JeffreyW;Cohen,JoshuaS
  • 通讯作者:
    Cohen,JoshuaS
Loss of diurnal rhythms of blood pressure and heart rate caused by high-fat feeding.
  • DOI:
    10.1016/j.amjhyper.2005.04.018
  • 发表时间:
    2005-10
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    J. Carroll;J. Thaden;Allison M Wright;Taylor Strange
  • 通讯作者:
    J. Carroll;J. Thaden;Allison M Wright;Taylor Strange
A comparison of two exercise training programs on cardiac responsiveness to beta-stimulation in obesity.
两种运动训练计划对肥胖患者心脏对 β 刺激的反应的比较。
Hydralazine as antihypertensive therapy in obesity-related hypertension.
肼屈嗪作为肥胖相关高血压的抗高血压治疗。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOAN F CARROLL其他文献

JOAN F CARROLL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOAN F CARROLL', 18)}}的其他基金

PULSE DOPPLER ULTRASOUND IMAGING SYSTEM: CARDIOVASCULAR
脉冲多普勒超声成像系统:心血管
  • 批准号:
    6973203
  • 财政年份:
    2004
  • 资助金额:
    $ 8.83万
  • 项目类别:
Pulse Doppler Ultrasound Imaging System
脉冲多普勒超声成像系统
  • 批准号:
    6732563
  • 财政年份:
    2004
  • 资助金额:
    $ 8.83万
  • 项目类别:
Systolic Cardiac Function in Obesity and Exercise
肥胖和运动中的心脏收缩功能
  • 批准号:
    6755177
  • 财政年份:
    2001
  • 资助金额:
    $ 8.83万
  • 项目类别:
Systolic Cardiac Function in Obesity and Exercise
肥胖和运动中的心脏收缩功能
  • 批准号:
    6638653
  • 财政年份:
    2001
  • 资助金额:
    $ 8.83万
  • 项目类别:
Systolic Cardiac Function in Obesity and Exercise
肥胖和运动中的心脏收缩功能
  • 批准号:
    6537821
  • 财政年份:
    2001
  • 资助金额:
    $ 8.83万
  • 项目类别:
Systolic Cardiac Function in Obesity and Exercise
肥胖和运动中的心脏收缩功能
  • 批准号:
    6370241
  • 财政年份:
    2001
  • 资助金额:
    $ 8.83万
  • 项目类别:
SYSTOLIC CARDIAC FUNCTION IN OBESITY AND EXERCISE
肥胖和运动中的心脏收缩功能
  • 批准号:
    6088020
  • 财政年份:
    2000
  • 资助金额:
    $ 8.83万
  • 项目类别:
SYSTOLIC CARDIAC FUNCTION IN OBESITY AND EXERCISE
肥胖和运动中的心脏收缩功能
  • 批准号:
    6526997
  • 财政年份:
    2000
  • 资助金额:
    $ 8.83万
  • 项目类别:
SYSTOLIC CARDIAC FUNCTION IN OBESITY AND EXERCISE
肥胖和运动中的心脏收缩功能
  • 批准号:
    6651539
  • 财政年份:
    2000
  • 资助金额:
    $ 8.83万
  • 项目类别:
SYSTOLIC CARDIAC FUNCTION IN OBESITY AND EXERCISE
肥胖和运动中的心脏收缩功能
  • 批准号:
    6388646
  • 财政年份:
    2000
  • 资助金额:
    $ 8.83万
  • 项目类别:

相似海外基金

Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Cardiac Beta-Adrenergic Receptor Density, Evaluated by Cardiac Positron Emission Tomography, in Heart Failure with Atrial Fibrillation
通过心脏正电子发射断层扫描评估心房颤动心力衰竭患者的心脏β-肾上腺素能受体密度
  • 批准号:
    22K07801
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for predictive indicators of therapeutic response of beta-adrenergic receptor blockers using myocardial tissue of patients with heart failure
利用心力衰竭患者心肌组织研究β-肾上腺素能受体阻滞剂治疗反应的预测指标
  • 批准号:
    21K16031
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
  • 批准号:
    10288087
  • 财政年份:
    2017
  • 资助金额:
    $ 8.83万
  • 项目类别:
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
  • 批准号:
    10063903
  • 财政年份:
    2017
  • 资助金额:
    $ 8.83万
  • 项目类别:
Beta adrenergic receptor resensitization in asthma
哮喘中的β肾上腺素能受体再敏化
  • 批准号:
    9205534
  • 财政年份:
    2016
  • 资助金额:
    $ 8.83万
  • 项目类别:
Impact of cardiac beta-adrenergic receptor density evaluated by cardiac PET on chronotropic incompetence
心脏 PET 评估心脏 β-肾上腺素能受体密度对变时性功能不全的影响
  • 批准号:
    15K09966
  • 财政年份:
    2015
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of the mechanism in the aldosterone regulation through the beta-adrenergic receptor
通过β-肾上腺素受体调节醛固酮的机制研究
  • 批准号:
    24580463
  • 财政年份:
    2012
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了